Developing a strong anion exchange/RP (SAX/RP) 2D LC system for high-abundance proteins depletion in human plasma

Proteomics

Volumn 12, Issue 23-24, 2012, Pages 3451-3463

  Zhu, Shaochun ^a   Zhang, Xueyang ^a   Gao, Mingxia ^a   Hong, Guangfeng ^a   Yan, Guoquan ^a   Zhang, Xiangmin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

High abundance; LC; Multidimensional LC; Plasma; Protein

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANGIOTENSINOGEN; ANTITHROMBIN III; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN D; APOLIPOPROTEIN E; APOLIPOPROTEIN L1; APOLIPOPROTEIN M; CERULOPLASMIN; CLUSTERIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT FACTOR H; GELSOLIN; HAPTOGLOBIN; HEMOPEXIN; HEPARIN COFACTOR II; PLASMA PROTEIN; PLASMINOGEN; SERUM ALBUMIN; TRANSCORTIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANION EXCHANGE; ARTICLE; HUMAN; LIQUID CHROMATOGRAPHY; PLASMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; ULTRAVIOLET SPECTROSCOPY; UNINDEXED SEQUENCE;

ANIONS; BLOOD PROTEINS; CHROMATOGRAPHY, ION EXCHANGE; HUMANS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84871280571     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200036     Document Type: Article

References (36)

1. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J. et al., Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteom. 2003, 2, 1096-1103.
2. Zolotarjova, N., Mrozinski, P., Majors, R. E., Removal and depletion of high-abundance proteins from biological fluids. LC GC N. Am. 2007, 25, 118-140.
3. Polaskova, V., Kapur, A., Khan, A., Molloy, M. P. et al., High-abundance protein depletion: comparison of methods for human plasma biomarker discovery. Electrophoresis 2010, 31, 471-482.
4. Tu, C. J., Rudnick, P. A., Martinez, M. Y., Cheek, K. L. et al., Depletion of abundant plasma proteins and limitations of plasma proteomics. J. Proteome Res. 2010, 9, 4982-4991.
5. Stempfer, R., Kubicek, M., Lang, I. M., Christa, N. et al., Quantitative assessment of human serum high-abundance protein depletion. Electrophoresis 2008, 29, 4316-4323.
6. Gong, Y., Li, X., Yang, B., Ying, W. T. et al., Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J. Proteome Res. 2006, 5, 1379-1387.
7. Faulkner, S., Elia, G., Hillard, M., O'Boyle, P. et al., Immunodepletion of albumin and immunoglobulin G from bovine plasma. Proteomics 2011, 11, 2329-2335.
8. Ichibangase, T., Moriya, K., Koike, K., Imai, K., Limitation of immunoaffinity column for the removal of abundant proteins from plasma in quantitative plasma proteomics. Biomed. Chromatogr. 2009, 23, 480-487.
9. Gao, M. X., Deng, C. H., Yu, W. J., Zhang, Y. et al., Large scale depletion of the high-abundance proteins and analysis of middle- and low-abundance proteins in human liver proteome by multidimensional liquid chromatography. Proteomics 2008, 8, 939-947.
10. VerBerkmoes, N. C., Bundy, J. L., Hauser, L., Asano, K. G. et al., Integrating "top-down" and "bottom-up" mass spectrometric approaches for proteomic analysis of Shewanella oneidensis. J. Proteome Res. 2002, 1, 239-252.
11. Faca, V., Pitteri, S. J., Newcomb, L., Glukhova, V. et al., Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J. Proteome Res. 2007, 6, 3558-3565.
12. Keller, A., Eng, J., Zhang, N., Li, X. J. et al., A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol. Syst. Biol. 2005, 1, 2005.0017.
13. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
14. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
15. Pepaj, M., Wilson, S. R., Novotna, K., Lundanes, E. et al., Two-dimensional capillary liquid chromatography: pH gradient ion exchange and reversed phase chromatography for rapid separation of proteins. J. Chromatogr. A 2006, 1120, 132-141.
16. Tran, B. Q., Loftheim, H., Reubsaet, L., Lundanes, E. et al., On-line multitasking analytical proteomics: how to separate, reduce, alkylate and digest whole proteins in an on-line multidimensional chromatography system coupled to MS. J. Separat. Sci. 2008, 31, 2913-2923.
17. Pepaj, M., Lundanes, E., Greibrokk, T., Separation of apolipoprotein A-I from human plasma by on-line two dimensional liquid chromatography. J. Liq. Chrom. Relat. Tech. 2007, 30, 1879-1894.
18. Jacobs, J. M., Adkins, J. N., Qian, W. J., Liu, T. et al., Utilizing human blood plasma for proteomic biomarker discovery. J. Proteome Res. 2005, 4, 1073-1085.
19. Gilar, M., Olivova, P., Daly, A. E., Gebler, J. C., Orthogonality of separation in two-dimensional liquid chromatography. Anal. Chem. 2005, 77, 6426-6434.
20. Hortin, G. L., Sviridov, D., Anderson, N. L., High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 2008, 54, 1608-1616.
21. Haab, B. B., Geierstanger, B. H., Michailidis, G., Vitzthum, F. et al., Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 2005, 5, 3278-3291.
22. Weinberg, R., Patton, C., Dague, B., Analytic and preparative separation of Apolipoprotein-A-I, Apolipoprotein-A-II, and Apolipoprotein-A-IV by reverse phase high-pressure liquid-chromatography. J. Lipid Res. 1988, 29, 819-824.
23. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W. et al., Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005, 5, 3226-3245.
24. Rizzo, M., Cappello, F., Marfil, R., Nibali, L. et al., Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study. Cell Stress Chaperones 2012, 17, 399-407.
25. Calandra, T., Roger, T., Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3, 791-800.
26. Stoppe, C., Fries, M., Rossaint, R., Grieb, G. et al., Blood levels of macrophage migration inhibitory factor after successful resuscitation from cardiac arrest. PLoS One 2012, 7, 10, e33512.
27. Sun, S., Poon, R. T., Lee, N. P., Yeung, C. et al., Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (
28. Shin, S. J., Kim, B. C., Kim, T. I., Lee, S. K. et al., Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behcet's disease. Dig. Dis. Sci. 2011, 56, 812-818.
29. Saulot, V., Vittecoq, O., Charlionet, R., Fardellone, P. et al., Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 2002, 46, 1196-1201.
30. Chen, W. T., Chang, S. C., Ke, T. W., Chiang, H. C. et al., Identification of biomarkers to improve diagnostic sensitivity of sporadic colorectal cancer in patients with low preoperative serum carcinoembryonic antigen by clinical proteomic analysis. Clin. Chim. Acta. 2011, 412, 636-641.
31. Ferraris, A. M., Giuntini, P., Gaetani, G. F., Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas. Blood 1979, 54, 928-932.
32. Li, H., Li, J., Wang, Y., Yang, T., Proteomic analysis of effluents from perfused human heart for transplantation: identification of potential biomarkers for ischemic heart damage. Proteome Sci. 2012, 10, 21.
33. Chen, Y., Zhang, H., Xu, A., Li, N. et al., Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Canc. 2006, 54, 95-102.
34. Takasaki, Y., Kaneda, K., Matsushita, M., Yamada, H. et al., Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients. Int. Immunol. 2004, 16, 1295-1304.
35. Takahashi, T., Takasaki, Y., Takeuchi, K., Yamanaka, K. et al., Detection of proliferating cell nuclear antigen (PCNA) in peripheral blood mononuclear cells and sera of patients with malignant lymphoma. Leuk. Lymphoma 1997, 28, 113-125.
36. Gu, X., Deng, C. H., Yan, G. Q., Zhang, X. M., Capillary array reversed-phase liquid chromatography-based multidimensional separation system coupled with MALDI-TOF-TOF-MS detection for high-throughput proteome analysis. J. Proteome Res. 2006, 5, 3186-3196.